Latest Angiotech Pharmaceuticals Inc. Stories
VANCOUVER, March 2 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has obtained a new Senior Secured Term Loan and Revolving Credit Facility. Wells Fargo Foothill, LLC is the sole arranger, administrative agent and lender for both the Term Loan and Revolving Credit Facility. The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured revolving credit facility with a borrowing base derived from the...
VANCOUVER, Feb. 26 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has received 510(k) clearance to begin marketing the Quill(TM) SRS Polydioxanone (PDO), MONODERM(TM) and Nylon product lines in Canada. "With the approval of the PDO, MONODERM(TM) and Nylon product lines in Canada, we can further extend the global reach of this next-generation suture product beyond the...
VANCOUVER, Feb. 24 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced a time change of its fourth quarter and year end conference call. The call will take place at 10:00 AM ET (7:00 AM PT) on Thursday, March 5, 2009. Dial information for the earnings call on March 5, 2009 has not changed and is as follows: North America (toll-free): (800) 291-9234 International:...
FOURTH QUARTER AND YEAR END 2008 FINANCIAL RESULTS VANCOUVER, Feb. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2008 on Thursday, March 5, 2009 at 11:00 AM ET (8:00 AM Pacific). Dial information for the earnings call on March 5, 2009 is as follows: North America...
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today announced that its 2008 annual and special general meeting of shareholders will take place on October 30, 2008 at 8:30am Pacific time, at the Sheraton Vancouver Wall Centre, 1088 Burrard Street, Vancouver, BC V6Z 2R9. The record date for shareholders entitled to receive notice of and vote at the meeting will be September 30, 2008,...
VANCOUVER, Sept. 22 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today announced that it is pursuing various initiatives to reduce operating costs and to further focus its business efforts, pending continued exploration of alternatives to the Company's balance sheet and current capital structure. Options to be explored, among others, include determining whether the Company will be able to consummate...
VANCOUVER, Sept. 10 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today announced that its corporate partner, Cook Medical, has completed enrollment in the first international clinical trial of a drug-eluting stent designed to treat arterial blockages outside the coronary arteries. The 420 patients enrolled in Cook's randomized trial of its Zilver PTX Drug Eluting Peripheral Stent include peripheral...
VANCOUVER, Aug. 12 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced that it has received CE Mark approval to begin marketing the HemoStream(TM) Chronic Dialysis Catheter in Europe. This CE Mark approval follows Angiotech's announcement in August 2007 that it had received clearance from the U.S. Food and Drug Association (FDA) to begin marketing HemoStream in the United States. In April of the same year,...
VANCOUVER, July 15 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the second quarter ended June 30, 2008. Monday, July 28, 2008 at 11:00 AM ET (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): (800) 706-7745 International: (617) 614-3472 Enter passcode: 52264044 A live...
VANCOUVER, March 7 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced the appointment of Victor Diaz as Senior Vice President, Global Manufacturing & Supply Chain Management. "With his significant accomplishments in manufacturing and supply chain operations in health care and the medical device industries, we are pleased to welcome Victor to Angiotech's senior management team," said Dr. William Hunter,...
